TURINABOL 20 mg 50 Tabs Nakon Medical USA
€63.81
Product Short Description
TURINABOL 20 mg 50 Tabs Nakon Medical USA delivers chlorodehydromethyltestosterone (C21H28ClO2), the 4-chloro-17α-methyl-Δ¹-testosterone derivative exhibiting lean anabolic response (~180:50 ratio) with minimal aromatization, at 20 mg strength characteristic of East German Tbol formulations. Domestic U.S. production eliminates customs exposure serving DEA Schedule III compliant institutional channels through verified performance networks.
Product Overview
Nakon Medical USA’s Turinabol 20 mg presents CDMT, featuring 4-chloro substitution and C1,2 unsaturation conferring non-aromatizing anabolic activity with 17α-methylation enabling oral bioavailability (~16 hour half-life), in small round scored tablets replicating historical Oral-Turinabol morphology for institutional catalog integration across DEA-registered platforms. The 50-tablet HDPE bottle supports CIII-compliant inventory reconciliation under 21 CFR 1304.22 requiring Schedule III accountability for institutional handlers.
U.S.-domiciled GMP manufacturing maintains molecular specifications (MW 360.91) distinguishing legitimate pedigree from underground conversions showing potency variance. This presentation serves buyers requiring Form 222 documentation across U.S. jurisdictions, avoiding grey-market risks.
Nakon positions within verified DEA Schedule III ecosystems for licensed clientele under 21 CFR 1301.13, excluding therapeutic claims.
Brand & Manufacturer Information
Nakon Medical USA manufactures Schedule III substances through domestic GMP facilities serving institutional networks with DEA verification. Turinabol 20 mg fits Nakon’s non-aromatizing oral catalog authenticating legitimacy versus powder alternatives rejected by handlers.
Domestic warehousing supports Form 222 platforms with serialized lots verifying 20 mg potency via HPLC, essential for procurement.
Active Compound Information
Contains chlorodehydromethyltestosterone (4-chloro-17α-methyl-Δ¹-testosterone), exhibiting 4-chloro modification preventing aromatization while maintaining anabolic potency characteristic of 17α-methyl steroids. DEA Schedule III reflects hepatotoxicity and virilization potential; WADA S1.1a prohibited with long-term metabolites detectable months post-administration.
20 mg strength matches historical GDR dosing; formula C21H28ClO2.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | TURINABOL 20 mg 50 Tabs Nakon Medical USA |
| Active Compound | Chlorodehydromethyltestosterone (C21H28ClO2) |
| Strength | 20 mg per round scored tablet |
| Quantity | 50 tablets per HDPE bottle |
| Form | Oral scored tablets |
| Category | DEA Schedule III controlled substance |
| Appearance | White, round, single-scored |
| Molecular Weight | 360.91 g/mol |
| Half-Life | ~16 hours |
| Label Elements | “20 mg”, CIII warnings, lot code |
Quality Control & Testing Standards
20 mg CDMT requires USP <621> HPLC assay (90-110%), USP <711> dissolution, and chloro-substitution verification. Nakon verifies C21H28ClO2 identity distinguishing GMP from underground sources.
CIII packaging meets USP <671> with ICH Q1A(R2) stability for extended shelf-life.
Intended Use & Market Positioning
Targets DEA-registered CIII institutional researchers via encrypted fulfillment with Form 222 accountability.
No protocols or outcomes represented in CIII positioning.
Legal & Regulatory Disclaimer
CDMT is DEA Schedule III under 21 USC §812; non-medical handling violates CSA (5 years/$250,000 penalties). Buyers assume DEA liability; no claims provided.
You must be logged in to post a review.
Reviews
There are no reviews yet.